Written question asked by Lord Mann (Labour) on Tuesday, 29 October 2002, in the House of Commons. It was due for an answer on Tuesday, 5 November 2002. It was answered by Hazel Blears (Labour) on Tuesday, 5 November 2002 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what information he intends to provide to patients regarding the safe (a) transport, (b) storage and (c) use of biological drugs.

Answer: John Mann: To ask the Secretary of State for Health what information he intends to provide to patients regarding the safe (a) transport, (b) storage and (c) use of biological drugs. [78489] Ms Blears: information regarding the transport, storage and use of biological drugs is specifically provided on the product label and, in more detail, in the patient information leaflet (PIL). The PIL is supplied with the packaged product. Information and advice on transport, storage and handling of each medicinal product is based upon the scientific data, including the stability of the drug in the final packaging, which is evaluated as part of the marketing authorisation application.

Secondary information